Search
for
Sort by
Research 181–210 of 206
- The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
- The α-Lipoic acid derivative sodium zinc dihydrolipoylhistidinate reduces chemotherapy-induced alopecia in a rat model: A pilot study
- Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
- Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling
- Knowledge Mapping of Drug Repositioning’s Theme and Development
- Quality of Life of Patients with Metastatic Breast Cancer Treated with Epirubicin and Docetaxel
- Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Drug-induced scarring and permanent alopecia
- Plumbagin, a Natural Compound with Several Biological Effects and Anti-Inflammatory Properties
- Optimizing hair care products and practices for Black patients with breast cancer: One size does not fit all
- Folliculotropic Mycosis Fungoides: Update on Diagnosis, Clinicopathological Stage, and Management
- Oxidative stress: Insights into the Pathogenesis and Treatment of Alopecia
- Repurposing of Various Current Medicines as Radioprotective Agents
- Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study
- Calreticulin: non‐endoplasmic reticulum functions in physiology and disease
- Prophylaxis and Management of Skin Toxicities
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- A 32‐year‐old woman with arthralgias and severe hypotension
- Approach to the patient with hair loss
- p63 in skin homeostasis and disease: molecular mechanisms and therapeutic potentials
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Systems for Mitochondria-Protective Cosmetic Actives: Opportunities in Post-Oncologic Skin Regeneration
- The Impact of Chemotherapy on the Nutritional Status of Breast Cancer Patients
- 28-Year-Old Female with Diffuse Thinning of the Scalp after Isotretinoin and Oral Contraceptives
- Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- Resfriamento de couro cabeludo para prevenção de alopecia induzida por quimioterapia: Estudo descritivo
- Efficacy and tolerability of scalp cooling in preventing alopecia during (neo)adjuvant chemotherapy for breast cancer
- Scalp cooling versus standard cold-cap in preventing chemotherapy-induced alopecia in patients with localized breast cancer: ICELAND protocol, a randomized controlled trial and economic evaluation